The use of salivary stimulant pastilles to improve compliance in women taking oxybutinin hydrochloride for detrusor instability.
Arango
O
O
D000781:Anethole Trithione / Q000627:therapeutic use; D001964:Bromhexine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008333:Mandelic Acids / Q000009:adverse effects*; D010276:Parasympatholytics / Q000009:adverse effects*; D010349:Patient Compliance; D012464:Saliva, Artificial / Q000008:administration & dosage*; D013607:Tablets; D014549:Urinary Incontinence / Q000188:drug therapy*
D008333:Mandelic Acids; D010276:Parasympatholytics; D012464:Saliva, Artificial; D013607:Tablets; C005419:oxybutynin; D001964:Bromhexine; D000781:Anethole Trithione